Upstream Bio, Inc. (UPB)
NASDAQ: UPB · Real-Time Price · USD
6.62
+0.21 (3.28%)
Jul 30, 2026, 3:04 PM EDT - Market open
Upstream Bio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Equivalents | 96.72 | 101.58 | 325.89 | 25.83 | 17.05 |
Short-Term Investments | 197.86 | 239.93 | 144.56 | 83.98 | - |
Cash & Short-Term Investments | 294.58 | 341.51 | 470.45 | 109.81 | 17.05 |
Cash Growth | -31.71% | -27.41% | 328.42% | 544.01% | - |
Accounts Receivable | 1.03 | 0.67 | 0.61 | 0.1 | 0.41 |
Other Current Assets | 20.67 | 9.62 | 8.1 | 7.09 | 0.84 |
Total Current Assets | 316.28 | 351.8 | 479.16 | 117 | 18.31 |
Net Property, Plant & Equipment | 1.58 | 1.78 | 2.37 | 0.2 | 0.16 |
Other Long-Term Assets | 0.19 | 0.19 | 0.19 | - | 0.01 |
Total Assets | 318.05 | 353.77 | 481.72 | 117.2 | 18.48 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Accounts Payable | 1.71 | 2.73 | 4.04 | 1.99 | 0.71 |
Accrued Expenses | 11.24 | 10.01 | 5.99 | 4.48 | 4.06 |
Current Portion of Leases | 0.72 | 0.72 | 0.7 | 0.05 | 0.09 |
Total Current Liabilities | 13.67 | 13.45 | 10.74 | 6.52 | 4.86 |
Long-Term Leases | 0.39 | 0.55 | 1.13 | 2.87 | 0.01 |
Other Long-Term Liabilities | - | - | - | - | 6.95 |
Total Long-Term Liabilities | 0.39 | 0.55 | 1.13 | 2.87 | 6.95 |
Total Liabilities | 14.06 | 14 | 11.87 | 9.39 | 11.81 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Common Stock | 0.05 | 0.05 | 0.05 | 0 | 0 |
Additional Paid-in Capital | 678.66 | 673.41 | 660.6 | 4.82 | 1.28 |
Accumulated Other Comprehensive Income | 0.1 | 0.53 | -0.03 | 0.02 | - |
Retained Earnings | -374.81 | -334.22 | -190.78 | -127.97 | -107.44 |
Total Common Shareholders' Equity | 304 | 339.77 | 469.85 | -123.13 | -106.16 |
Shareholders' Equity | 304 | 339.77 | 469.85 | 230.94 | 112.82 |
Total Liabilities & Equity | 318.05 | 353.77 | 481.72 | 117.2 | 18.48 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Total Debt | 1.11 | 1.27 | 1.83 | 2.92 | 0.09 |
Net Cash (Debt) | 293.47 | 340.24 | 468.62 | 106.89 | 16.96 |
Net Cash Growth | -31.70% | -27.40% | 338.41% | 530.37% | - |
Net Cash Per Share | 5.43 | 6.32 | 34.25 | 36.19 | 5.77 |
Book Value | 304 | 339.77 | 469.85 | -123.13 | -106.16 |
Book Value Per Share | 5.63 | 6.31 | 34.34 | -41.68 | -36.14 |
Tangible Book Value | 304 | 339.77 | 469.85 | -123.13 | -106.16 |
Tangible Book Value Per Share | 5.63 | 6.31 | 34.34 | -41.68 | -36.14 |